3.4.15.1	additional information	the purified mucilage of storage roots (Ipomoea batatas (L.) Lam. Tainong 57) exhibits dose-dependent ACE inhibitory activity in vitro. The mucilage acted as a mixed type inhibitor toward ACE with an IC50 of 0.3645 mg/ml	2	
3.4.15.1	additional information	angiotensin-converting enzyme inhibitors are recommended in dogs and cats with chronic renal failure. They decrease the glomerular capillary pressure, have antiproteinuric effects, tend to delay the progression of chronic renal failure and to limit the extent of renal lesions	2	
3.4.15.1	additional information	tissue angiotensin converting enzyme inhibitors exert more pronounced antithrombotic effect than plasma ACE-Is in experimental thrombosis	2	
3.4.15.1	additional information	the immobilized enzyme is used to purify inhibitory peptides from sunflower	2	
3.4.15.1	additional information	the immobilized lung extract is used to purify inhibitory peptides from sunflower and rapeseed protein hydrolysates that has been obtained by treatment of protein isolates with alcalase	2	
3.4.15.1	additional information	simultaneous determination of angiotensin I-converting enzyme inhibitory peptides in tryptic casein hydrolysate by high-performance liquid chromatography combined with a replicate heart-cut column-switching technique	2	
3.4.15.1	additional information	inhibitory peptide is isolated from tuna dark muscle hydrolysate prepared by alcalase, neutrase, pepsin, papain, alpha-chymotrypsin, and trypsin, respectively. Among hydrolysates, the pepsin-derived hydrolysate exhibited the highest ACE I inhibitory activity versus those of other enzyme hydrolysates. The structure of the peptide is identified to be Trp-Pro-Glu-Ala-Ala-Glu-Leu-Met-Met-Glu-Val-Asp-Pro	2	
3.4.15.1	additional information	yak milk casein could be a resource to generate antihypertensive peptides	2	
3.4.15.1	additional information	angiotensin I-converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease D3	2	
3.4.15.1	additional information	trichloroacetic acid filtrates of lactic acid bacteria (Lactobacillus casei 2607, Lactobacillus casei 15286, Lactobacillus acidophilus 4461, Lactobacillus acidophilus 33200, Streptococcus thermophilus 1275, Streptococcus thermophilus 285, Lactobacillus delbrueckii ssp. bulgaricus 1092, Lactobacillus delbrueckii ssp. bulgaricus 1368, Bifidobacterium longum 5022) show inhibitory activity	2